Literature DB >> 11140775

Other child and adolescent psychiatric disorders: medication aspects.

J S Werry1.   

Abstract

Childhood/adolescent onset not covered elsewhere, in supplement 9:I of the European Child and Adolescent Psychiatry, where there is some indication that pharmacotherapy might have a role, are reviewed. These include conduct, oppositional, mood, schizophrenia spectrum and anxiety disorders other than obsessive compulsive disorders. Generally speaking, there is a paucity of good studies in young persons. Most of these disorders or their equivalents have some pharmacotherapeutic indications in adults. This supplements the scant data in young persons and supports the cautious use of medication in some of these disorders, especially where the disorder is severe and disabling (such as schizophrenia or bipolar mood disorder). Much more study of pharmacotherapy of these disorders is indicated.

Entities:  

Mesh:

Year:  2000        PMID: 11140775     DOI: 10.1007/s007870070025

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  4 in total

1.  'Schizoid' personality in childhood and adult life. I: The vagaries of diagnostic labelling.

Authors:  S Wolff
Journal:  Br J Psychiatry       Date:  1991-11       Impact factor: 9.319

2.  Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions.

Authors:  G N Clarke; P Rohde; P M Lewinsohn; H Hops; J R Seeley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-03       Impact factor: 8.829

3.  Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder.

Authors:  R G Klein; H Abikoff; E Klass; D Ganeles; L M Seese; S Pollack
Journal:  Arch Gen Psychiatry       Date:  1997-12

4.  Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor.

Authors:  J S March; L Amaya-Jackson; M C Murray; A Schulte
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-06       Impact factor: 8.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.